22 October 2014

Introduction to Epigenetic Drug Discovery

Organised by:

SCI’s Young Chemists' Panel

Nuffield Department of Medicine Research Building, Oxford, UK

Registration Closed

This event is no longer available for registration.

Synopsis
Epigenetics is a rapidly expanding area of research whose importance for the generation of novel therapeutics is becoming increasingly apparent.

This is the second meeting organised by SCI's Young Chemists' Panel covering this emerging area of drug discovery. The aim of the day is to provide participants with a fundamental understanding of Epigenetics and how it relates to Drug Discovery, from an introduction to the underpinning biology and the discovery of novel therapeutic targets to the development of chemical probes and small molecule inhibitors. The day will comprise of a series of lectures from some of the leading names in Epigenetic research from both UK academia and industry. The day will close with a question and answer session which all of the speakers will be involved in.
Attendees

The meeting is aimed at those studying for a postgraduate degree in the area of medicinal chemistry or working in pharmaceutical or biotechnology industries, in particular those wishing to gain a greater understanding of the fundamental aspects of this emerging area of drug discovery.

Programme

Day 1

09:30
Registration and refreshments
10:00
Welcome and introduction
10:10
Epigenetic drug discovery - why it matters and why it’s tough
Nessa Carey, PraxisUnico
10:40
Selective targeting of protein interactions mediated by epigenetic reader domains
Stefan Knapp, SGC
11:30
Refreshments
11:55
Synergy of multiple hit identification approaches and structural biology to find epigenetic modulators
Chun-wa Chung, GlaxoSmithKline
12:35
Developing inhibitors of the bromodomain-histone interaction
Stuart Conway, University of Oxford
13;15
Lunch
14:05
The KDM5 histone demethylases as targets in drug discovery
Peter Staller, Epitherapeutics
14:45
The design and synthesis of selective Peptidyl Arginine Deiminase 4 (PAD4) tool inhibitors
Stephen Atkinson, GlaxoSmithKline
15:25
Paul Brennan, SGC
16:05
Closing remarks and wine reception
Accessibility Grants

SCI accessibility grants are available to support SCI members with disabilities, long term health conditions, those who require a carer, and members who are nursing parents to attend SCI events. Download an application form to apply for a grant.

Venue and Contact

Structural Genomics Consortium

Nuffield Department of Medicine Research Building
University of Oxford
Old Road Campus
Headington
Oxford, OX3 7FZ

 

Conference Team

Tel: +44 (0)20 7598 1561

Email: conferences@soci.org

Fees
SCI Member GB£80
SCI Student Member GB£30
SCI Subsidised Member GB£55
Non-Member GB£110


Standard Rate - after 12 September 2014

SCI Member GB£100
SCI Student Member GB£35
SCI Subsidised Member GB£65
Non-Member GB£130

Become an SCI Member and save on this and future events

See Membership Options

Sign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations

Booking Process/Deadlines
For booking terms and conditions click here.
 
Additional Info

Organising Committee

Ben Buckley, Loughborough University
Tom Hayhow, GlaxoSmithKline
Michael Lainchbury, Argenta
Ben Whittaker, Biofocus